Sylvant Interactions
There are 226 drugs known to interact with Sylvant (siltuximab), along with 4 disease interactions. Of the total drug interactions, 44 are major, 175 are moderate, and 7 are minor.
- View all 226 medications that may interact with Sylvant
- View Sylvant disease interactions (4)
Most frequently checked interactions
View interaction reports for Sylvant (siltuximab) and the medicines listed below.
- Actemra (tocilizumab)
- Alprolix (coagulation factor ix)
- Amevive (alefacept)
- Amicar (aminocaproic acid)
- AquADEKs (multivitamin with minerals)
- Aralast NP (alpha 1-proteinase inhibitor)
- Aranesp (darbepoetin alfa)
- Austedo (deutetrabenazine)
- Baraclude (entecavir)
- Berinert (C1 esterase inhibitor (human))
- Biaxin (clarithromycin)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Butisol Sodium (butabarbital)
- Bydureon (exenatide)
- Calquence (acalabrutinib)
- Caprelsa (vandetanib)
- Carimune NF (immune globulin intravenous)
- Complera (emtricitabine / rilpivirine / tenofovir)
- Cosentyx (secukinumab)
- Cotellic (cobimetinib)
- Creon (pancrelipase)
- Crysvita (burosumab)
- Cytovene (ganciclovir)
- Cytoxan Lyophilized (cyclophosphamide)
- Detrol LA (tolterodine)
- Diacomit (stiripentol)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- Xadago (safinamide)
Sylvant disease interactions
There are 4 disease interactions with Sylvant (siltuximab) which include:
More about Sylvant (siltuximab)
- Sylvant consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.